Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
46,493,166
-
Share change
-
+11,444,024
-
Total reported value
-
$1,034,139,433
-
Put/Call ratio
-
42%
-
Price per share
-
$22.24
-
Number of holders
-
140
-
Value change
-
+$269,937,051
-
Number of buys
-
95
-
Number of sells
-
34
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2020
As of 31 Dec 2020,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,493,166 shares.
The largest 10 holders included
Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, and STATE STREET CORP.
This page lists
140
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.